Sandoz to buy eye drug Cimerli for $170mln
Swiss company, Sandoz announced a $170 million purchase agreement to acquire Cimerli, eye biosimilar medication.
Browsing Tag
Novartis
Novartis: it’s ‘too soon’ to know whether malaria drug could be coronavirus vaccine
Swiss pharma giant Novartis on Friday has cautioned that it is “too soon” to be sure whether two anti-malaria drugs…
Novartis boosts Q3 profit, pushes Alcon decision to 2019
Novartis's third-quarter core net income surged 4 percent at constant currencies, beating expectations, as the…
Europe stocks open higher
Stock markets in Europe opened higher on Wednesday as the earnings season continues. The pan-European Stoxx 600 was…
European stocks open higher; earnings to dominate
European stocks traded higher morning Tuesday with corporate earnings dominating market moves. The pan-European…
Novartis splits drugs business into two, pharma chief to leave
Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on…
Europe Stock-Index Futures Rise on China Production Data
European stock-index futures advanced, indicating equities may snap two days of losses, as China’s industrial…
Europe Shares Inch Lower Ahead of EU Summit
European stock markets inched lower on Monday as investors were closely monitoring euro-zone events ahead of a…
